Comparison Of Responder Rates Between Fremanezumab, Erenumab And Onabotulinumtoxina Among Patients With Migraine With >= 3 Prior Treatment Failures: A Network Meta-Analysis
JOURNAL OF HEADACHE AND PAIN(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要